NasdaqCM - Nasdaq Real Time Price • USD
iCAD, Inc. (ICAD)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 6:16 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 2 |
Avg. Estimate | -0.06 | -0.06 | -0.23 | -0.18 |
Low Estimate | -0.08 | -0.08 | -0.29 | -0.24 |
High Estimate | -0.05 | -0.05 | -0.19 | -0.13 |
Year Ago EPS | -0.15 | -0.07 | -0.19 | -0.23 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 2 |
Avg. Estimate | 4.44M | 4.48M | 18.51M | 23.51M |
Low Estimate | 4.33M | 4.3M | 18M | 20M |
High Estimate | 4.61M | 4.73M | 19.37M | 27.01M |
Year Ago Sales | 5.78M | 6.11M | 17.32M | 18.51M |
Sales Growth (year/est) | -23.20% | -26.70% | 6.90% | 27.00% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.11 | -0.11 | -0.09 | -0.05 |
EPS Actual | -0.15 | -0.07 | -0.05 | 0.05 |
Difference | -0.04 | 0.04 | 0.04 | 0.1 |
Surprise % | -36.40% | 36.40% | 44.40% | 200.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.06 | -0.06 | -0.23 | -0.18 |
7 Days Ago | -0.06 | -0.06 | -0.23 | -0.19 |
30 Days Ago | -0.06 | -0.06 | -0.23 | -0.19 |
60 Days Ago | -0.05 | -0.05 | -0.21 | -0.14 |
90 Days Ago | -0.05 | -0.05 | -0.21 | -0.14 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | 1 |
Up Last 30 Days | -- | -- | -- | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | ICAD | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 60.00% | -- | -- | 1.60% |
Next Qtr. | 14.30% | -- | -- | 10.50% |
Current Year | -21.10% | -- | -- | 5.20% |
Next Year | 21.70% | -- | -- | 13.30% |
Next 5 Years (per annum) | 15.00% | -- | -- | 11.22% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Maintains | Lake Street: Buy to Buy | 7/19/2023 |
Maintains | JMP Securities: Outperform | 4/13/2023 |
Maintains | Oppenheimer: Outperform | 4/4/2023 |
Maintains | BTIG: Buy | 3/29/2023 |
Maintains | Lake Street: Buy | 3/29/2023 |
Maintains | JMP Securities: Market Outperform | 9/1/2022 |
Related Tickers
IRIX IRIDEX Corporation
2.8700
-4.97%
PROF Profound Medical Corp.
7.75
-0.39%
NPCE NeuroPace, Inc.
13.98
-0.14%
KIDS OrthoPediatrics Corp.
30.31
+2.89%
LIVN LivaNova PLC
52.33
-0.82%
APYX Apyx Medical Corporation
1.3200
-4.35%
MODD Modular Medical, Inc.
1.6300
-4.68%
CVRX CVRx, Inc.
14.90
-2.36%
MDAI Spectral AI, Inc.
1.8100
-4.23%
OM Outset Medical, Inc.
2.3200
+3.11%